MEA Synthetic Biology Market

MEA Synthetic Biology Market Size (2023 to 2028)

The size of the Synthetic Biology Market in the Middle East & Africa is predicted to value USD 0.73 billion in 2023 and USD 1.95 billion by 2028, growing at a CAGR of 21.67% from 2023 to 2028.

Synthetic biology is a branch of science combining biology and engineering. It brings together several disciplines from these fields, such as genetic engineering, biotechnology, molecular engineering, computer engineering, and evolutionary biology. In synthetic biology, these disciplines are applied to build artificial biological systems in engineering, research, and medical applications.

To achieve the intended biological system through DNA modification or sequencing, technology plays a significant role. Computer-aided designs are needed to model the designs accurately, and techniques which can read and write DNA are instrumental. By combining advances in biology with modern technologies, organisms can produce several chemicals, enzymes, or biofuels.

Increasing expenditure on research and development of biotechnology and pharmaceutical companies, increasing demand for genetically modified crops, and significant technological advancements in DNA studies are the significant factors driving the market growth. In addition, increasing demand for alternate fuels such as biofuels and growing popularity for protein therapeutics are also expected to propel market growth.

However, ethical concerns regarding biosafety and biosecurity and stringent regulations are hindering the growth of the market.

This research report on the MEA synthetic biology market has been segmented & sub-segmented into the following categories:

By Tool: 

Chassis Organisms

• Cloning & Assembly Kits
• Oligonucleotide Synthesis
• Enzymes
• Xeno Nucleic Acid

By Technology: 

• Enabling technologies
  • Gene Synthesis
  • Cloning and Sequencing
  • Genome Engineering
  • Bioinformatics
  • Nanotechnology
  • Site-Directed Mutagenesis
  • Microfluidics
  • Measurement and Modelling
• Enabled technologies
  • Next-Generation Sequencing
  • Pathway Engineering

By Application: 

• Medical
• Environmental
• Industrial

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the MEA synthetic biology market is projected to account for a considerable share in the global market during the forecast period. The market share is attributed to the increasing number of healthcare & life science facilities and growing demand for effective vaccines and drugs. In addition, the major companies are investing heavily in research and development, which is helping to fuel the increasing demands for synthetic biology tools and technologies among academic and research institutes and healthcare providers in MEA. On the other hand, South Africa, Saudi Arabia, and the United Arab Emirates significantly contribute to the regional market growth.

The South Africa synthetic biology market dominated the MEA market in 2022 and accounted for the higher share in the region. The government's increasing investment, rising number of well-established synthetic biology companies and research institutions, and growing awareness are fuelling the market growth. In addition, increasing healthcare spending and the adoption of advanced technology in the healthcare sector are further fuelling the market growth in South Africa.

On the other hand, developing countries such as Saudi Arabia and UAE are anticipated to witness a moderate share and expand the MEA synthetic biology market. Growing number of international alliances, strong government support is encouraging market growth. Moreover, the major companies are implementing various strategies such as partnerships, mergers, and acquisitions to gain a competitive advantage.

KEY MARKET PLAYERS:

Companies such as Dupont, Intrexon Corporation, Amyris, Inc., Genscript USA, Inc., Integrated Dna Technologies (IDT), Inc., Novozymes, Royal DSM N.V, New England Biolabs, Inc., Synthetic Genomics, Inc., and Thermo Fisher Scientific, Inc. are playing a pivotal role in the MEA Synthetic Biology Market.